Kyriakos K.

Passionate about #strategy, #healthcare and #exploring the #world. More in LinkedIn: Kyriakos Konstantinidis

[Prof Sir Mene Pangalos FRS @MenePangalos]

Goodness what a graph.. the most used vaccine globally ⁦@UniofOxford⁩ ⁦@AstraZeneca⁩

[Prof Sir Mene Pangalos FRS @MenePangalos]

Shocked and devastated by today’s news of José’s passing. He was a brilliant oncologist, a fantastic drug developer and a wonderful, inspiring and challenging colleague. We have lost a special and irreplaceable person today.

[Kyriakos K. @kyrkon]

#NewProfilePic

[AstraZeneca @AstraZeneca]

It’s a fact: up to 1 in 5 people who have experienced a heart attack may go on to have another within one year. More can be done to reduce this risk in patients across the globe, and at #AHA19, we present data with the aim to improve outcomes for patients.

[AstraZeneca @AstraZeneca]

Our new R&D and AI centres in Shanghai, announced at #CIIE2019, expands our scientific focus in China and reinforces our commitment to partnership and improving healthcare in the country and around the world. https://t.co/2ZR8UqHH0V

[AstraZeneca @AstraZeneca]

Even after surviving a #heartattack, patients are left feeling worried or scared of experiencing another one. But support is available. We aim to help improve the clinical practice and contribute to a seamless disease management pathway for patients.

[AstraZeneca @AstraZeneca]

Geoff didn’t realise he was close to experiencing a #heartattack or #stroke. But he now knows that with the right changes, this risk can be reduced. Watch @FixingDad to learn more. #ESCCongress https://t.co/VCdMcB8TUK

[AstraZeneca @AstraZeneca]

A number of lifestyle changes can help reduce the risk of people experiencing secondary cardiovascular events. Find out how to reduce the risk at https://t.co/XzIRVthPou

[AstraZeneca @AstraZeneca]

“And then the lights went out”. What is the risk of recurrent myocardial infarctions? Visit https://t.co/XzIRVthPou for more information.

[AstraZeneca @AstraZeneca]

People who survive one heart attack may have up to a 1 in 5 chance of experiencing another cardiovascular event within 1 year. Find out how to reduce this risk at https://t.co/XzIRVthPou

[AstraZeneca @AstraZeneca]

“No one should go through the horror of a second heart attack”. Find out how to reduce the risk at https://t.co/XzIRVthPou

[AstraZeneca @AstraZeneca]

Among myocardial infarction survivors, up to 20% may go on to have a subsequent cardiovascular event, including cardiovascular death, myocardial infarction or stroke within 1 year. Learn more about the risks: https://t.co/XzIRVthPou

[Kyriakos K. @kyrkon]

https://t.co/73dnzWeSBi

[Kyriakos K. @kyrkon]

https://t.co/lrXZzioXk3

[Kyriakos K. @kyrkon]

It’s been a year since…..the Cannes Lions Award. Ready to present the story behind. #TheAttack #CannesLions
Thank you @AstraZeneca for the opportunity to lead and create a award-winning disease awareness film.

[Kyriakos K. @kyrkon]

Last June I was awarded a Bronze Lion in @Cannes_Lions. This year i am invited to speak. What an honour! Cannot wait to be exposed to the best of the best. #canneslions #cannes2019 #18daystogo

[Kyriakos K. @kyrkon]

Incredibly proud to lead this campaign that aims to educate more patients and healthcare providers on how to reduce the risk of heart attack recurrence.
https://t.co/xI8DSTs0ln

[AstraZeneca @AstraZeneca]

“No one should go through the horror of a second heart attack.” Find out how to reduce the risk at https://t.co/yEsrql6X5m.

[Kyriakos K. @kyrkon]

AI in Healthcare IS the future!! Check out which pharma companies are best suited to succeed. #healthcare #biotech https://t.co/6MsL4j53qp

[Kyriakos K. @kyrkon]

Truly an mpressive pipeline for AstraZeneca! https://t.co/Q4cusId66i